November 18, 2026
Health news, explained with evidence
LIVE

New Study Identifies Distinct Metabolic Subtypes in Adult-Onset Type 1 Diabetes

❤️ Conditions & Care 2 min read 👁 16

Recent findings published in The Lancet highlight distinct metabolic and clinical subtypes among adults diagnosed with type 1 diabetes, revealing varied disease trajectories and complication risks.

New Study Identifies Distinct Metabolic Subtypes in Adult-Onset Type 1 Diabetes❤️Conditions & Care

Photo: medpagetoday.com

Key points

  • The Lancet study identified three distinct metabolic and antibody-based subtypes of adult type 1 diabetes.
  • GADA-positive patients were split into classic and mixed groups, differing in BMI, insulin sensitivity, and beta-cell function.
  • The mixed subtype was linked to higher risks of hypoglycemia, retinopathy, and cardiovascular autonomic neuropathy.

A recent prospective cohort study featured in The Lancet suggests that adult-onset type 1 diabetes is more heterogeneous than previously understood, highlighting three distinct metabolic subtypes. Researchers analyzed data from adults aged 18 to 69 with a clinical diagnosis of type 1 diabetes within the preceding 12 months, utilizing information from the German Diabetes Study to examine antibody profiles, metabolic markers, and disease progression.

The investigation focused heavily on patients possessing antibodies to glutamic acid decarboxylase (GADA). Within this GADA-positive population, investigators identified two separate groups: a classic type 1 subtype characterized by lower body mass index (BMI), high insulin sensitivity, and severe beta-cell dysfunction; and a mixed type 1 subtype featuring higher BMI, lower insulin sensitivity, and better preserved beta-cell function. Longitudinal data suggest the mixed group may represent an earlier, structurally distinct phase of the classic trajectory, occurring roughly six years prior.

A third group of participants tested GADA-negative, displaying different underlying antibodies, a more gradual decline in beta-cell function, and reduced genetic risk scores, pointing toward a pathogenetically distinct disease pathway. Furthermore, the mixed subtype exhibited higher risks for certain complications, including hypoglycemia, retinopathy, and cardiovascular autonomic neuropathy, compared to the classic group.

What to know: While these findings offer a deeper understanding of adult type 1 diabetes heterogeneity and point toward potential future avenues for targeted immunomodulatory treatments, the study is observational and requires further validation. Readers should always consult a qualified healthcare provider for personal medical advice and individualized treatment plans.

Source medpagetoday.com — medpagetoday.com/podcasts/healthwatch/123879 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.